Data / Form D filings / ORTHODATA INC
ORTHODATA INC: Form D filings
ORTHODATA INC, a pharmaceuticals company in Louisville, KY, filed 2 Form D notices with the SEC between 2009 and 2012. The latest, on May 11, 2012, reports $32,375 sold of a $70,000 offering to 8 investors.
Find out what ORTHODATA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 222 SOUTH FIRST STREET, SUITE 200, Louisville, KY, 40202
- Phone
- (502) 410-1652
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1434148
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2012 | New notice | $70,000 | $32,375 | $37,625 | 8 | May 1, 2012 | sec.gov |
| Dec 22, 2009 | New notice | $500,000 | $320,000 | $180,000 | 14 | Dec 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Emont | Director | |
| Steve Wilson | Director | |
| Richard Navarro | Executive Officer, Director | |
| John Naber | Director | |
| Timothy Prell | Director |
Every Form D from the week of May 7, 2012 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ORTHODATA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.